title: A possible association between takotsubo cardiomyopathy and treatment with flecainide.
authors.forename: Laurence
authors.initials: L
authors.lastname: Gabriel
authors.forename: Patrick
authors.initials: P
authors.lastname: Chenu
authors.forename: Antoine
authors.initials: A
authors.lastname: Guédès
authors.forename: Vincent
authors.initials: V
authors.lastname: Dangoisse
authors.forename: Baudouin
authors.initials: B
authors.lastname: Marchandise
authors.forename: Dominique
authors.initials: D
authors.lastname: Blommaert
authors.forename: Jacques
authors.initials: J
authors.lastname: Jamart
authors.forename: Luc
authors.initials: L
authors.lastname: De Roy
authors.forename: Erwin
authors.initials: E
authors.lastname: Schroeder
mesh_terms: D000368:Aged; D000889:Anti-Arrhythmia Agents / Q000009:adverse effects; D000075202:Contraindications; D005260:Female; D005424:Flecainide / Q000009:adverse effects*; D006801:Humans; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D055502:Secondary Prevention; D013577:Syndrome; D054549:Takotsubo Cardiomyopathy / Q000139:chemically induced* / Q000150:complications / Q000453:epidemiology*; D016896:Treatment Outcome
chemical_list: D000889:Anti-Arrhythmia Agents; D005424:Flecainide